Drugs known as SGLT2 inhibitors have become an important treatment option for people with type 2 diabetes. These medications help lower blood sugar by making the body remove extra glucose through the urine.
While they’ve been shown to work well for many people, a recent study by the U.S. Food and Drug Administration (FDA) has raised concerns about a rare but serious side effect.
The study found that some people taking SGLT2 inhibitors developed a dangerous infection called Fournier gangrene. This condition is very rare but can be life-threatening if not treated quickly. It affects the skin and soft tissues around the genital and anal area and can spread rapidly.
The FDA looked into the safety of several diabetes medications, including SGLT2 inhibitors, metformin, different types of insulin, and a few combination drugs. Their goal was to see if any serious problems were linked to these medicines.
One of the most alarming discoveries was the connection between SGLT2 inhibitors and Fournier gangrene. Between March 2013 and January 2019, the FDA found 55 cases of the infection in people using SGLT2 inhibitors. These patients ranged in age from 33 to 87 years old. Out of the 55 cases, 39 were men and 16 were women.
In comparison, only 19 similar cases were found among people taking other diabetes drugs over a much longer time—between 1984 and early 2019. This difference strongly suggests that there may be something about SGLT2 inhibitors that raises the risk for this type of infection.
In the 55 cases linked to SGLT2 inhibitors, the infection started anywhere from just a few days to over four years after beginning the treatment.
Along with Fournier gangrene, many of these patients also developed other serious problems like diabetic ketoacidosis (a dangerous buildup of acids in the blood), sepsis (a widespread infection), or kidney damage. These issues can make Fournier gangrene even harder to treat.
Fournier gangrene is rare, but it’s very serious. It usually starts with pain, redness, or swelling in the genital or anal area. People may also have fever, fatigue, or a general feeling of being unwell. Because it spreads quickly, early treatment is critical. In many cases, surgery is needed to remove the infected tissue, along with antibiotics and supportive care.
This study is a warning for doctors and patients. While SGLT2 inhibitors like canagliflozin, dapagliflozin, and empagliflozin can be very helpful for controlling blood sugar, their risks must also be considered. It’s important for patients to understand what to watch out for and to tell their doctor right away if they notice any symptoms in the genital or perineal area.
The FDA study points out a serious, though rare, risk linked to SGLT2 inhibitors. The fact that more than twice as many cases of Fournier gangrene were linked to these drugs over a shorter period compared to all other diabetes medications combined is concerning.
It’s also important to note that the infection happened in both men and women and could appear even years after starting the medication. This means long-term monitoring is needed, not just during the first few weeks or months of treatment.
However, this doesn’t mean everyone should stop using these drugs. SGLT2 inhibitors have proven benefits for many people. They not only help control blood sugar but can also reduce the risk of heart disease and kidney problems, which are common in people with diabetes.
Still, it’s clear that more awareness is needed. Doctors should warn patients about the early signs of Fournier gangrene and encourage them to seek medical help quickly if they notice anything unusual. At the same time, researchers should continue studying how and why this infection happens in people taking these drugs, so we can better prevent it.
In short, this study reminds us that even helpful medications can come with unexpected risks. The best way forward is open communication between patients and doctors, careful monitoring, and more research to keep improving diabetes care safely.
If you care about diabetes, please read studies about the cooking connection between potatoes and diabetes, and low calorie diets may help reverse type 2 diabetes.
For more health information, please see recent studies about protein power: a new ally in diabetes management, and pineapple and diabetes: A sweet surprise.
Copyright © 2025 Knowridge Science Report. All rights reserved.
